Computer-assisted evaluation of perianal fistula activity by means of anal ultrasound in patients with Crohn's disease

American Journal of Gastroenterology

Volumn 101, Issue 7, 2006, Pages 1551-1558

  Caprioli, Flavio ^a   Losco, Alessandra ^a   Viganò, Chiara ^a   Conte, Dario ^a   Biondetti, Pietro ^b   Forzenigo, Laura V ^b   Basilisco, Guido ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANUS FISTULA; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ECHOGRAPHY; EVALUATION; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; TECHNIQUE;

ADULT; AGED; ANUS DISEASES; CROHN DISEASE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECTAL FISTULA; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 33745583765     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00561.x     Document Type: Article

References (48)

1. Schwartz DA, Loftus EV, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875-80.
2. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001;121:1064-72.
3. Buchanan G, Halligan S, Williams A, et al. Effect of MRI on clinical outcome of recurrent fistula-in-ano. Lancet 2002;360:1661-2.
4. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterology 2003;125:1508-30.
5. Louis E, Vermeire S, Rutgeerts P, et al. A positive response to infliximab in Crohn's disease: Association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism. Scand J Gastroenterol 2002;37:818-24.
6. Boirivant M, Leoni M, Tariciotti D, et al. The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol 1988;10:401-5.
7. Rutgeerts P, Colombel J, Enns R, et al. Subanalysis from a phase 3 study on the evaluation of natalizumab in active Crohn's disease. Gut 2003;52:A239.
8. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
9. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350: 876-85.
10. Ardizzone S, Maconi G, Colombo E, et al. Perianal fistulae following infliximab treatment: Clinical and endosonographic outcome. Inflamm Bowel Dis 2004;10:91-6.
11. Van Bodegraven AA, Sloots CE, Felt-Bersma RJ, et al. Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum 2002:45;39-46.
12. Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003;98:332-9.
13. Bell SJ, Halligan S, Windsor AC, et al. Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2003;17:387-93.
14. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. J Clin Gastroenterol 1995;20:27-32.
15. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122:512-30.
16. Beets-Tan RG, Beets GL, van der Hoop AG, et al. Preoperative MR imaging of anal fistulas: Does it really help the surgeon? Radiology 2001;218:75-84.
17. Haggett PJ, Moore NR, Shearman JD, et al. Pelvic and perineal complications of Crohn's disease: Assessment using magnetic resonance imaging. Gut 1995;36:407-10.
18. Myhr GE, Myrvold HE, Nilsen G, et al. Perianal fistulas: Use of MR imaging for diagnosis. Radiology 1994;191: 545-9.
19. Hussain SM, Stoker J, Schouten WR, et al. Fistula in ano: Endoanal sonography versus endoanal MR imaging in classification. Radiology 1996;200:475-81.
20. Tissot O, Bodnar D, Henri L, et al. MR T2 weighted aspect of perianal fistulas. J Radiol 1996;77:253-60.
21. Bartram CI, Buchanan G. Imaging anal fistula. Radiol Clin N Am 2003;41:443-57.
22. Buchanan GN, Halligan S, Bartram CI, et al. Clinical examination, endosonography, and MR imaging in pre-operative assessment of fistula in ano: Comparison with outcome-based reference standard. Radiology 2004;233: 674-81.
23. Law PJ, Talbot RW, Bartram CI, et al. Anal endosonography in the evaluation of perianal sepsis and fistula in ano. Br J Surg 1989;76:752-5.
24. Lattanzi F, Bellotti P, Picano E, et al. Quantitative texture analysis in two-dimensional echocardiography: Application to the diagnosis of myocardial hemochromatosis. Echocardiography 1996;13:9-20.
25. Adelson EH. Perceptual organization and judgment of brightness. Science 1993;262:2042-4.
26. Gilchrist AL. The perception of surface blacks and whites. Sci Am 1979;240:112-22.
27. Morita Y, Takiguchi M, Yasuda J, et al. Endoscopic and transcutaneous ultrasonographic findings and grey-scale histogram analysis in dogs with caerulein-induced pancreatitis. Vet Q 1998;20:89-92.
28. Sands BE. Crohn's disease. In: Feldman M, Friedman LS, Sleisenger MH, eds. Gastrointestinal and liver disease, 7th Ed. Philadelphia: Saunders, 2002.
29. The Standards Practice Task Force, The American Society of Colon and Rectal Surgeons. Practice parameters for treatment of fistula in ano: supporting documentation. Dis Colon Rectum 1996;39:1363-72.
30. Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976;63:1-12.
31. Bartram CI, Frudinger A. Handbook of anal endosonography. Petersfield: Wrightson Biomedical Publishing, 1997.
32. Kundel HL, Polansky M. Measurement of observer agreement. Radiology 2003;228:303-8.
33. Machin D, Campbell M, Fayers P, et al. Sample size tables for clinical studies, 2nd Ed. Oxford: Blackwell, 1997.
34. El-Barghouty NM, Levine T, Ladva S, et al. Histological verification of computerised carotid plaque characterisation. Eur J Vasc Endovasc Surg 1996;11:414-6.
35. Biasi GM, Sampaolo A, Mingazzini P, et al. Computer analysis of ultrasonic plaque echolucency in identifying high risk carotid bifurcation lesions. Eur J Vasc Endovasc Surg 1999;17:476-9.
36. Schiemann U, Gellner R, Riemann B, et al. Standardized grey scale ultrasonography in Graves' disease: Correlation to autoimmune activity. Eur J Endocrinol 1999;141:332-6.
37. Gronholdt ML, Nordestgaard BG, Wiebe BM, et al. Echolucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation 1998;97:34-40.
38. Mayor I, Momjian S, Lalive P, et al. Carotid plaque: Comparison between visual and grey-scale median analysis. Ultrasound Med Biol 2003;29:961-6.
39. El-Atrozy T, Nicolaides A, Tegos T, et al. The effect of B-mode ultrasonic image standardisation on the echodensity of symptomatic and asymptomatic carotid bifurcation plaques. Int Angiol 1998;17:179-86.
40. Fanchin R, Righini C, Olivennes F, et al. Computerized assessment of endometrial echogenicity: Clues to the endometrial effects of premature progesterone elevation. Fertil Steril 1999;71:174-81.
41. Williams AB, Bartram CI, Halligan S, et al. Multiplanar anal endosonography-normal anal canal anatomy. Colorectal Dis 2001;3:169-74.
42. West RL, Zimmerman DDE, Dwarkasing S, et al. Prospective comparison of hydrogen peroxide-enhanced three-dimensional endoanal ultrasonography and endoanal magnetic resonance imaging of perianal fistulas. Dis Colon Rectum 2003;46:1407-15.
43. West RL, Dwarkasing S, Felt-Bersma RJF, et al. Hydrogen peroxide-enhanced three-dimensional endoanal ultrasonography and endoanal magnetic resonance imaging in evaluating perianal fistulas: Agreement and patient preference. Eur J Gastroenterol Hepatol 2004;16:1319-24.
44. Christensen AF, Nielsen MB, Engelholm SA, et al. Three-dimensional anal endosonography may improve staging of anal cancer compared with two-dimensional endosonography. Dis Colon Rectum 2004;47:341-5.
45. Christensen AF, Nyhuus B, Nielsen MB, et al. Three-dimensional anal endosonography may improve diagnostic confidence of detecting damage to the anal sphincter complex. Br J Radiol 2005;78:308-11.
46. Ratto C, Grillo E, Parello A, et al. Endoanal ultrasound-guided surgery for anal fistula. Endoscopy 2005;37:722-8.
47. Buchanan GN, Bartram CI, Williams AB, et al. Value of hydrogen peroxide enhancement of three-dimensional endoanal ultrasound in fistula-in-ano. Dis Colon Rectum 2005;48:141-7.
48. Maor Y, Chowers Y, Koller M, et al. Endosonographic evaluation of perianal fistulas and abscesses: Comparison of two instruments and assessment of the role of hydrogen peroxide injection. J Clin Ultrasound 2005;33:226-32.